|
Ladnov D.V., Kulik V.V., Kirpichnikov S.I., Shaporova N.L.
Mild forms of COVID-19: the clinical course features in patients with chronic obstructive pulmonary disease
|
№8 / 2021
|
|
Naumov A.V., Prokofieva T.V., Polunina O.S., Saroyants L.V., Lipnitskaya E.A., Polunina E.A.
Levels of apoptosis indicators in patients with myocardial infarction on the background of chronic obstructive pulmonary disease depending on the time of development of myocardial ischemia
|
№6 / 2021
|
|
Korneeva N.V., Khelimskaya I.V., Kim Ch.O., An A.S., Schennikov E.L., Belun I.F., Praslova N.Yu.
Analysis of smoking behavior in patients with chronic obstructive pulmonary disease
|
№5 / 2020
|
|
Varvarina G.N., Makarova E.V., Plastinina S.S., Milyutina M.Y., Menkov N.V., Saltsev S.G.
Obstructive pulmonary diseases and disorders of carbohydrate metabolism: hospital patients hypoglycemia is focused on
|
№6 / 2019
|
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
|
Mayorova M.V., Grigorieva N.Yu., Samolyuk M.O.
The role of endothelial dysfunction and oxidative stress in the formation of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease
|
№5 / 2019
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Peculiarities of chronic heart failure in COPD patients
|
№5 / 2019
|
|
Malyavin A.G., Avksentieva M.V., Babak S.L., Dzanaeva A.V.
Medical and economical consequences of extension of medicamentally support program for patients with COPD in Russia
|
№5 / 2019
|
|
Adasheva T.V., Bolieva L.Z., Lee V.V., Malyavin A.G.
Use of beta-blockers in COPD: mythical risk or justified benefit?
|
№5 / 2019
|
|
Zhdankin A.V., Nikishkina D.R., Solodun M.V.
Clinical case of tumor in a rare localization
|
№4 / 2019
|
|
Epishina Ya.S., Khazov D.A., Solodun M.V.
Clinical case of the bronchial obstruction syndrome: COPD or asthma?
|
№3 / 2019
|
|
Statsenko M.E., Lopushkova Yu.E., Derevyanchenko M.V.
Study of arterial stiffness and C-reactive protein level in patients with chronic heart failure and chronic obstructive pulmonary disease
|
№1 / 2019
|
Русский
